Rationale for using recombinant human erythropoietin to treat the anemia of prematurity

Contrib Nephrol. 1989:76:324-8; discussion 328-9. doi: 10.1159/000417909.
No abstract available

Publication types

  • Review

MeSH terms

  • Anemia / blood
  • Anemia / drug therapy*
  • Anemia / therapy
  • Blood Transfusion
  • Erythropoietin / therapeutic use*
  • Hematocrit
  • Humans
  • Infant
  • Infant, Newborn
  • Infant, Premature

Substances

  • Erythropoietin